# KEY PHARMACEUTICAL
> **Judicial** · FY1987 · — · Final Order With Penalty
## Case
- **Activity ID:** `2497`
- **Case Number:** 02-1987-0254
- **Type:** Judicial
- **Lead:** EPA
- **Outcome:** Final Order With Penalty
- **Penalty assessed:** $170K
- **Cost recovery:** —
- **Compliance action $:** —
- **Multimedia (multi-env):** N
## Defendants
- KEY PHARMACEUTICAL (complaint) (settlement)
## Summary

DEFENDANT, KEY PHARMACEUTICAL, A WHOLLY OWNED SUBSIDIARY   OF SCHERING-PLOUGH INC., OPERATES A PHARMACEUTICAL MANUFAC-  TURING PLANT IN LAS PIEDRAS, PR, AND HAS REPEATEDLY VIOLATED ITS NPDES PERMIT OVER THE PAST 18 MONTHS.                      A PROPOSED CONSENT DECREE HAS BEEN EXECUTED.  THE REGION   HAS REACHED A SETTLEMENT WITH DEFENDANT PROVIDING FOR        $170,000 IN UP-FRONT PENALTIES FOR PAST VIOLATIONS, SUBSTAN- TIAL STIPULATED PENALTIES FOR VIOLATIONS OF THE DECREE, AND  A COMPLIANCE SCHEDULE FOR TREATMENT PLANT MODIFICATIONS AND  A REPORTING SCHEDULE.  IT IS ANTICIPATED THAT THE CONSENT    DECREE AND THE COMPLAINT BE FILED SIMULTANEOUSLY.              THIS FACILITY WAS THE SUBJECT OF A NOTICE OF CITIZENS SUIT FILED BY ATLANTIC STATES LEGAL FOUNDATION (ASLF), A CITIZEN  UNDER SECTION 505 OF THE CWA.  REGION II HAS KEPT ASLF AP-   PRISED OF OUR ACTIONS IN THIS MATTER, AND WE UNDERSTAND,     THAT, SHOULD SETTLEMENT OF THIS MATTER ALONG THE LINES OF    THE PROPOSED CONSENT DECREE OCCUR, ASLF WILL NOT FILE A SEP- ARATE ACTION.

---
*Source: [EPA ECHO](https://echo.epa.gov/) · AI Analytics · CC0 1.0*